IMMUNE DISEASE INSTITUTE, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 2253
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
C07K PEPTIDES 2134
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS147
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8021668 Integrin alpha L I domain mutants with increased binding affinityDec 12, 06Sep 20, 11[A61K, C07K]
7943589 siRNA microbicides for preventing and treating diseasesJun 05, 06May 17, 11[A61K, C07H, C12Q]
7816490 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseasesOct 28, 08Oct 19, 10[C07K]
7696179 Inhibition of gene expression using RNA interfering agentsOct 29, 03Apr 13, 10[A61K, A01N]
7442783 Natural IgM antibodies and inhibitors thereofMar 01, 05Oct 28, 08[C07H]
5460945 Device and method for analysis of blood components and identifying inhibitors and promoters of the inflammatory responseMay 20, 92Oct 24, 95[C12Q, C12N, G01N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0129,752 TARGETED DELIVERY TO LEUKOCYTES USING PROTEIN CARRIERSAbandonedApr 25, 07May 23, 13[A61K, C12N, C07K]
2013/0040,845 METHOD FOR SCREENING RECEPTORS/LIGANDS INTERACTIONSAbandonedFeb 14, 11Feb 14, 13[G01N, C40B]
2012/0087,973 siRNA MICROBICIDES FOR PREVENTING AND TREATING DISEASESAbandonedMar 23, 11Apr 12, 12[A61K, C12N, A61P]
2011/0212,100 METHODS FOR MODULATING DEVELOPMENT AND EXPANSION OF IL-17 EXPRESSING CELLSAbandonedAug 15, 08Sep 01, 11[A61K, A61P]
2011/0177,155 METHODS OF DELIVERY OF AGENTS TO LEUKOCYTES AND ENDOTHELIAL CELLSAbandonedAug 20, 08Jul 21, 11[A61K, C12N]
2010/0310,583 LET-7 MICRORNA AND MIMETICS THEREOF AS THERAPEUTICS FOR CANCERAbandonedJan 31, 08Dec 09, 10[A61K, A61P]
2010/0285,002 TREATMENT OR PREVENTION OF INFLAMMATION BY TARGETING CYCLIN D1AbandonedDec 30, 08Nov 11, 10[A61K, A61P]
2010/0273,859 TREATMENT AND PREVENTION OF HIV INFECTIONAbandonedDec 15, 08Oct 28, 10[A61K, C07H, A61P]
2010/0135,910 Modulation of Anergy and Methods for Isolating Anergy-Modulating CompoundsAbandonedJun 03, 09Jun 03, 10[A61K, G01N, A61P]
2010/0136,684 Natural IgM AntibodiesAbandonedAug 28, 09Jun 03, 10[C12N, C07K]
2010/0008,937 TARGETED DELIVERY TO LEUKOCYTES USING NON-PROTEIN CARRIERSAbandonedApr 25, 07Jan 14, 10[A61K, C07H, C12N, C07K]
2009/0232,730 METHOD OF PRODUCING IMMUNOLIPOSOMES AND COMPOSITIONS THEREOFAbandonedApr 24, 07Sep 17, 09[A61K, A61B]
7572949 SKN-1 and GSK-3 genes and proteinsExpiredJun 14, 04Aug 11, 09[A61K, A01K]
2009/0176,966 Natural IGM Antibodies and Inhibitors ThereofAbandonedOct 28, 08Jul 09, 09[C07K]
2009/0047,338 Method to Treat Flavivirus Infection with siRNAAbandonedOct 05, 06Feb 19, 09[A61K, A61P]
2008/0227,733 Method for Treating and Preventing Ischemia-Reperfusion Injury Using Rna Interfering AgentAbandonedNov 01, 04Sep 18, 08[A61K, A01N, C12N, A61P]
2004/0131,607 Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injuryAbandonedOct 06, 03Jul 08, 04[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.